‘We’re Fighting For Our Lives’: Patients Protest Sky-High Insulin Prices
The price of insulin keeps going up. For people with Type 1 diabetes, high prices can be a life-or-death issue. Now a grass-roots movement is pushing for change.
Drugs
901-920 of 1,325 results
-
-
No Cash, No Heart. Transplant Centers Require Proof Of Payment.
The case of a Michigan woman told to fundraise $10,000 for a heart transplant sparked viral outrage, but experts say “wallet biopsies” are common.
-
Readers And Tweeters Demand Action On Gun Violence, Mental Health Care Options
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
-
Government Investigation Finds Flaws In the FDA’s Orphan Drug Program
A probe by the Government Accountability Office cites breakdowns in the Food and Drug Administration program that approves drugs for rare diseases.
By Sarah Jane Tribble and Sydney Lupkin -
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
-
Podcast: KHN’s ‘What The Health?’ Reading The Tea Leaves In Blue Wave’s Wake
In this episode of KHN’s “What the Health?” Mary Agnes Carey of Kaiser Health News, Margot Sanger-Katz of The New York Times, Alice Ollstein of Politico and Anna Edney of Bloomberg News discuss the impact of House Democratic leadership elections and their impact on health policy; as well as efforts by the Trump administration to address high drug prices and ensure the safety of medical devices. Plus, Julie Rovner interviews KHN’s Jay Hancock about the latest “Bill of the Month.”
-
Democrats Winning Key Leadership Jobs Have Taken Millions From Pharma
Top House Republican also received more than $1 million from drugmakers since 2007.
-
Fish Oil Drug Looks Heart-Healthy. Just Don’t Swallow It Hook, Line And Sinker.
The complete findings of a recent study show the FDA-approved drug Vascepa reduced the likelihood of cardiovascular death, stroke and other heart conditions in some patients. But science didn’t find the same promise for over-the-counter fish oil supplements when tested in healthy people.
-
New Congress To Tackle Burning Health Care Issues, Including Drug Prices
KHN’s Sarah Jane Tribble discusses the twists and turns with CBS News.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
-
Podcast: KHN’s ‘What The Health?’ Doctors, Guns And Lame Ducks
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Rebecca Adams of CQ Roll Call, Kimberly Leonard of the Washington Examiner and Alice Ollstein of Politico discuss how the Democrats’ takeover of the House and other results from the Nov. 6 elections might affect health care, and what Congress may have in store for the lame-duck session.
-
Childbirth In The Age Of Addiction: New Mom Worries About Maintaining Sobriety
For mothers in recovery from opioid addiction, narcotic pain relief during and after delivery can put sobriety at risk.
-
Fish Oil And Vitamin D Pills No Guard Against Cancer Or Serious Heart Trouble
And new study finds no reason to get routine vitamin D tests, researchers say.
By Liz Szabo -
Podcast: KHN’s ‘What The Health?’ Split Decision On Health Care
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Rebecca Adams of CQ Roll Call and Joanne Kenen of Politico discuss the Trump administration’s new birth control coverage rules and the potential impact of the midterm election results on health policy.
-
House Dems In New Seats Of Power Will Steer Health Policy, Attack Drug Prices
Democrats, who have a history of championing the Affordable Care Act and railing about drug prices, will now chair several house committees.
-
Heart Drug Spotlights Troubling Trends In Drug Marketing
Critics worry the marketing of Vascepa, a purified fish oil product, could prove a fish story.
-
Pricey Precision Medicine Often Financially Toxic For Cancer Patients
Medical treatments targeting the DNA in tumor cells are celebrated, but insurers often won’t cover the skyrocketing cost.
By Liz Szabo -
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
-
Trump Adds A Global Pricing Plan To Wide Attack On Drug Prices, But Doubts Persist
Over the past five months, the Trump administration has proposed a series of reforms to lower the cost of prescription drugs.
-
Podcast: KHN’s ‘What The Health?’ Trump, GOP Fight Back On Health Care
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Kimberly Leonard of the Washington Examiner and Alice Ollstein of Politico discuss a flurry of proposals from the Trump administration on prices Medicare pays for drugs and the Affordable Care Act.